The Patient Protection and Affordable Care Act, which passed in March 2010, has created new regulations regarding the purchase of over-the-counter (OTC) drugs and medicines through employee FSAs and HRAs. On September 3, 2010, the IRS issued official guidance in Notice 2010-59.